Iovance Biotherapeutics (IOVA)
(Real Time Quote from BATS)
$8.32 USD
+0.36 (4.52%)
Updated Jul 22, 2024 03:49 PM ET
After-Market: $8.34 +0.02 (0.24%) 4:16 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.32 USD
+0.36 (4.52%)
Updated Jul 22, 2024 03:49 PM ET
After-Market: $8.34 +0.02 (0.24%) 4:16 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Zacks News
Are Options Traders Betting on a Big Move in Iovance Biotherapeutics (IOVA) Stock?
by Zacks Equity Research
Investors need to pay close attention to Iovance Biotherapeutics (IOVA) stock based on the movements in the options market lately.
Cancer-Fighting Stocks & ETF: What You Need to Know
by Neena Mishra
Many biotech stocks soared after they presented very promising cancer treatment results at the ASCO conference
Why Cancer-Fighting Stocks & ETFs Are Soaring
by Neena Mishra
The cancer immunotherapy ETF is soaring today as some of its holdings presented very promising results at the ASCO conference. Find out more on the podcast.
Implied Volatility Surging for Iovance Biotherapeutics (IOVA) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Iovance Biotherapeutics (IOVA) stock based on the movements in the options market lately.
Are Options Traders Betting on a Big Move in Lion Biotechnologies (IOVA) Stock?
by Zacks Equity Research
Investors need to pay close attention to Lion Biotechnologies (IOVA) stock based on the movements in the options market lately.
Iovance Biotherapeutics (IOVA) Jumps: Stock Rises 5.1%
by Zacks Equity Research
Iovance Biotherapeutics (IOVA) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Implied Volatility Surging for Iovance Biotherapeutics (IOVA) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Iovance Biotherapeutics (IOVA) stock based on the movements in the options market lately.
Is a Surprise Coming for Lion Biotechnologies (IOVA) This Earnings Season?
by Zacks Equity Research
Lion Biotechnologies (IOVA) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.
Iovance Biotherapeutics (IOVA) in Focus: Stock Moves 5.1% Higher
by Zacks Equity Research
Iovance Biotherapeutics (IOVA) shares rose more than 5% in the last trading session, amid huge volumes.